<DOC>
	<DOC>NCT01992380</DOC>
	<brief_summary>This study will test if two 18F-AV-1451 PET scans up to 4 weeks apart in healthy volunteers, MCI and AD subjects provide the same results.</brief_summary>
	<brief_title>A Study of 18F-AV-1451 in Healthy Volunteers and Cognitively Impaired Subjects</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Healthy Volunteers Male or female subjects ≥ 50 years of age Minimental state examination (MMSE) ≥ 29 MCI Subjects Male or female subjects ≥ 50 years of age MMSE ≥ 24 Have MCI consistent with National Institute on AgingAlzheimer's Association (NIAAA) working group's diagnostic guidelines for AD Have a study partner that can report on subject's activities of daily living Probable AD Subjects Male or female subjects ≥ 50 years of age MMSE &gt; 10 Meet clinical criteria for probable AD based on the NIAAA working group's diagnostic guidelines for AD Have a study partner that can report on subject's activities of daily living Current clinically significant psychiatric disease Evidence of structural brain abnormalities Evidence of dementing illness other than AD Current clinically significant cardiovascular disease or ECG abnormalities, or additional risk factors for Torsades de Pointes Current clinically significant infectious disease, endocrine or metabolic disease, pulmonary, renal or hepatic impairment, or cancer History of alcohol or substance abuse or dependence Females of childbearing potential who are not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception Have received or participated in a trial with investigational medications in the past 30 days have had a nonstudy related radiopharmaceutical imaging or treatment procedure within 7 days prior to the study imaging session.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>